Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new Studentship has been announced in memory of the late MRC HIU Director and MRC WIMM Group Leader.

MRC HIU Director and MRC WIMM Group Leader Professor Vincenzo Cerundolo FRS

Professor Vincenzo Cerundolo FRS (1959-2020) was Director of the MRC HIU from 2010-2020 and a leader in the field of immunology, whose research advanced our understanding of antigen processing and presentation to immune cells.

Thanks to generous donations from friends, family and colleagues, a new Studentship has been set up in his honour.

The Enzo Cerundolo Scholarship at the University of Oxford will support a DPhil student in the Medical Sciences Division undertaking research in the field of human immunology.



“I am delighted that this Scholarship has now been established. It will provide a permanent reminder of Enzo who was a great scientist, a lovely colleague and a great mentor to his students”.

 - Professor Doug Higgs

Similar stories

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.

Showcasing Oxford’s translational research for Rare Disease Day

Rare Disease Day is an annual awareness day that aims to educate and raise awareness for the 400 million people worldwide who live with a rare disease.

Prostate cancer AI diagnosis tool begins evaluation in Oxford

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.